Results 101 to 110 of about 689 (161)

Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma. [PDF]

RNA
Liu B, Murphy A, Benton A, Gartenhaus L, Budka W, Bronzini JM, Hartzler S, Yates ME, Alzate AR, Janson ND, Jayasundara S, Utturkar S, Lanman NA, Kazemian M, Hanna JA.   +14 more
europepmc   +1 more source

Stenotrophomonas maltophilia complex: A broadly distributed emerging pathogen. [PDF]

PLoS Pathog
Crisan CV, Goldberg JB.
europepmc   +1 more source

Gatekeepers of Pain: A Scoping Review on How Nanoparticle Engineering Illuminates Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Targeting. [PDF]

Cureus
Xiang AQ, Cho E, Jiang T, Balraj N, Abu-Baker S.   +4 more
europepmc   +1 more source

GM-CSF orchestrates monocyte and granulocyte responses to Cryptococcus gattii. [PDF]

PLoS Pathog
Ricafrente A, Acharya S, Chen S, Abass A, Arshakyan A, Olson TJ, Trivedi A, Heung LJ.   +7 more
europepmc   +1 more source

For the Creative Spirits Out There: BioéthiqueOnline Inaugurates a Publication Venue for Creative and Artistic Works in Bioethics / Pour les esprits créatifs émergents: BioéthiqueOnline inaugure une section spéciale pour les travaux créatifs et artistiques en matière de bioéthique

BioéthiqueOnline, 2013
Behrmann, Jason
doaj  

Metformin enhances TRAIL-mediated antitumor activity of liver natural killer cells in mice. [PDF]

Sci Rep
Bekki T, Ohira M, Imaoka Y, Imaoka K, Niitsu H, Tanaka Y, Kobayashi T, Ohdan H.   +7 more
europepmc   +1 more source

Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids. [PDF]

Cancer Res
Gillette A, Udgata S, Schmitz AE, Stoecker JN, Kratz JD, Deming DA, Skala MC.   +6 more
europepmc   +1 more source

Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy. [PDF]

PLoS Pathog
Zhu X, Luo Z, Leonard RA, Hamele CE, Spreng RL, Heaton NS.   +5 more
europepmc   +1 more source

An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins. [PDF]

Nat Commun
Puente-Massaguer E, Galdino Andrade T, Scherm MJ, Vasilev K, Abozeid H, Rodriguez AJ, Yueh J, Bhavsar D, Campbell JD, Yu D, Webby RJ, Kawaoka Y, Neumann G, Han J, Ward AB, Krammer F.   +15 more
europepmc   +1 more source

Neurotransmitter-Mediated Signaling in Glioblastoma and Glial Tumors: Biology and Therapeutic Opportunities. [PDF]

Oncol Res
Tralongo P, Ballato M, Zuccalà V, Fiorentino V, Giordano W, Casili G, Bellinghieri F, Caruso G, Angileri FF, Fadda G, Martini M, Caffo M.   +11 more
europepmc   +1 more source